Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 951937, 10 pages
http://dx.doi.org/10.1155/2014/951937
Research Article

Endometrial Receptivity Profile in Patients with Premature Progesterone Elevation on the Day of hCG Administration

1CHU Montpellier, Institut de Recherche en Biothérapie, Hôpital Saint-Eloi, 34295 Montpellier, France
2INSERM U1040, Hôpital Saint-Eloi, 34295 Montpellier, France
3Université Montpellier 1, UFR de Médecine, Equipe “Développement Embryonnaire Précoce et Cellules Souches Embryonnaires Humaines”, 34000 Montpellier, France
4OVO Fertility, 8000 Boulevard Decarie No. 100, Montréal, QC, Canada H4P 2S4
5CHU Montpellier, ART/PGD Division, Département de Biologie de la Reproduction, Hôpital Arnaud de Villeneuve, 34295 Montpellier, France
6Laboratoire Dynabio, Polyclinique du Cotentin, 50120 Equeurdreville, France
7CHU Montpellier, Hôpital Gui de Chauliac, Service Anatomie Cytologie Pathologiques, 34295 Montpellier, France
8CHU Léonard de Vinci-Université Paris XIII, Service de Médecine de la Reproduction, Hôpital Jean Verdier, 93143 Bondy, France

Received 16 December 2013; Revised 3 April 2014; Accepted 3 April 2014; Published 28 April 2014

Academic Editor: Javeed Iqbal

Copyright © 2014 Delphine Haouzi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Schoolcraft, E. Sinton, T. Schlenker, D. Huynh, F. Hamilton, and D. R. Meldrum, “Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate,” Fertility and Sterility, vol. 55, no. 3, pp. 563–566, 1991. View at Google Scholar · View at Scopus
  2. K. M. Silverberg, W. N. Burns, D. L. Olive, R. M. Riehl, and R. S. Schenken, “Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins,” Journal of Clinical Endocrinology and Metabolism, vol. 73, no. 4, pp. 797–803, 1991. View at Google Scholar · View at Scopus
  3. Y. Mio, A. Sekijima, T. Iwabe, Y. Onohara, T. Harada, and N. Terakawa, “Subtle rise in serum progesterone during the follicular phase as a predictor of the outcome of in vitro fertilization,” Fertility and Sterility, vol. 58, no. 1, pp. 159–166, 1992. View at Google Scholar · View at Scopus
  4. A. Shulman, Y. Ghetler, Y. Beyth, and I. Ben-Nun, “The significance of an early (premature) rise of plasma progesterone in in vitro fertilization cycles induced by a “long protocol” of gonadotropin releasing hormone analogue and human menopausal gonadotropins,” Journal of Assisted Reproduction and Genetics, vol. 13, no. 3, pp. 207–211, 1996. View at Google Scholar · View at Scopus
  5. E. Bosch, I. Valencia, E. Escudero et al., “Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome,” Fertility and Sterility, vol. 80, no. 6, pp. 1444–1449, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Bosch, E. Labarta, J. Crespo et al., “Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles,” Human Reproduction, vol. 25, no. 8, pp. 2092–2100, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. A. N. Andersen, P. Devroey, and J.-C. Arce, “Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial,” Human Reproduction, vol. 21, no. 12, pp. 3217–3227, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Xu, Z. Li, H. Zhang et al., “Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles,” Fertility and Sterility, vol. 97, pp. 1321–1327.e4, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. E. M. Kolibianakis, C. A. Venetis, J. Bontis, and B. C. Tarlatzis, “Significantly lower pregnancy rates in the presence of progesterone elevation in patients treated with GnRH antagonists and gonadotrophins: a systematic review and meta-analysis,” Current Pharmaceutical Biotechnology, vol. 13, no. 3, pp. 464–470, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Doldi, E. Marsiglio, A. Destefani, A. Gessi, G. Merati, and A. Ferrari, “Elevated serum progesterone on the day of HCG administration in IVF is associated with a higher pregnancy rate in polycystic ovary syndrome,” Human Reproduction, vol. 14, no. 3, pp. 601–605, 1999. View at Google Scholar · View at Scopus
  11. M. C. Edelstein, H. J. Seltman, B. J. Cox, S. M. Robinson, R. A. Shaw, and S. J. Muasher, “Progesterone levels on the day of human chorionic gonadotropin administration in cycles with gonadotropin-releasing hormone agonist suppression are not predictive of pregnancy outcome,” Fertility and Sterility, vol. 54, no. 5, pp. 853–857, 1990. View at Google Scholar · View at Scopus
  12. C. R. Givens, E. D. Schriock, P. V. Dandekar, and M. C. Martin, “Elevated serum progesterone levels on the day of human chorionic gonadotropin administration do not predict outcome in assisted reproduction cycles,” Fertility and Sterility, vol. 62, no. 5, pp. 1011–1017, 1994. View at Google Scholar · View at Scopus
  13. M. Bustillo, J. J. Stern, and C. B. Coulam, “Serum progesterone at the time of human chorionic gonadotrophin does not predict pregnancy in in-vitro fertilization and embryo transfer,” Human Reproduction, vol. 10, no. 11, pp. 2862–2867, 1995. View at Google Scholar · View at Scopus
  14. M. I. Abuzeid and M. A. Sasy, “Elevated progesterone levels in the late follicular phase do not predict success of in vitro fertilization-embryo transfer,” Fertility and Sterility, vol. 65, no. 5, pp. 981–985, 1996. View at Google Scholar · View at Scopus
  15. G. E. Hofmann, J. Khoury, C. A. Johnson, J. Thie, and J. Scott R.T., “Premature luteinization during controlled ovarian hyperstimulation for in vitro fertilization-embryo transfer has no impact on pregnancy outcome,” Fertility and Sterility, vol. 66, no. 6, pp. 980–986, 1996. View at Google Scholar · View at Scopus
  16. F. Ubaldi, C. Albano, M. Peukert et al., “Subtle progesterone rise after the administration of the gonadotrophin-releasing hormone antagonist Cetrorelix in intracytoplasmic sperm injection cycles,” Human Reproduction, vol. 11, no. 7, pp. 1405–1407, 1996. View at Google Scholar · View at Scopus
  17. D. V. Moffitt, J. T. Queenan Jr., B. S. Ruth Shaw, and S. J. Muasher, “Progesterone levels on the day of human chorionic gonadotropin do not predict pregnancy outcome from the transfer of fresh or cryopreserved embryos from the same cohort,” Fertility and Sterility, vol. 67, no. 2, pp. 296–301, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Urman, C. Alatas, S. Aksoy, R. Mercan, A. Isiklar, and B. Balaban, “Elevated serum progesterone level on the day of human chorionic gonadotropin administration does not adversely affect implantation rates after intracytoplasmic sperm injection and embryo transfer,” Fertility and Sterility, vol. 72, no. 6, pp. 975–979, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Martínez, B. Coroleu, E. Clua et al., “Serum progesterone concentrations on the day of HCG administration cannot predict pregnancy in assisted reproduction cycles,” Reproductive BioMedicine Online, vol. 8, no. 2, pp. 183–190, 2004. View at Google Scholar · View at Scopus
  20. C. A. Venetis, E. M. Kolibianakis, E. Papanikolaou, J. Bontis, P. Devroey, and B. C. Tarlatzis, “Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis,” Human Reproduction Update, vol. 13, no. 4, pp. 343–355, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. H. A. Saleh, M. S. E.-A. Omran, and M. Draz, “Does subtle progesterone rise on the day of HCG affect pregnancy rate in long agonist ICSI cycles?” Journal of Assisted Reproduction and Genetics, vol. 26, no. 5, pp. 239–242, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Labarta, J. A. MartÍnez-Conejero, P. Alamá et al., “Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis,” Human Reproduction, vol. 26, no. 7, pp. 1813–1825, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Li, J. Qiao, L. Wang et al., “MicroRNA array and microarray evaluation of endometrial receptivity in patients with high serum progesterone levels on the day of hCG administration,” Reproductive Biology and Endocrinology, vol. 9, article 29, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Kolibianakis, C. Bourgain, C. Albano et al., “Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up,” Fertility and Sterility, vol. 78, no. 5, pp. 1025–1029, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Simon, J. Oberyé, J. Bellver et al., “Similar endometrial development in oocyte donors treated with either high- or standard-dose GnRH antagonist compared to treatment with a GnRH agonist or in natural cycles,” Human Reproduction, vol. 20, no. 12, pp. 3318–3327, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. I. Van Vaerenbergh, L. Van Lommel, V. Ghislain et al., “In GnRH antagonist/rec-FSH stimulated cycles, advanced endometrial maturation on the day of oocyte retrieval correlates with altered gene expression,” Human Reproduction, vol. 24, no. 5, pp. 1085–1091, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. I. Van Vaerenbergh, H. M. Fatemi, C. Blockeel et al., “Progesterone rise on HCG day in GnRH antagonist/rFSH stimulated cycles affects endometrial gene expression,” Reproductive BioMedicine Online, vol. 22, no. 3, pp. 263–271, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Haouzi, K. Mahmoud, M. Fourar et al., “Identification of new biomarkers of human endometrial receptivity in the natural cycle,” Human Reproduction, vol. 24, no. 1, pp. 198–205, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Haouzi, S. Assou, K. Mahmoud et al., “Gene expression profile of human endometrial receptivity: comparison between natural and stimulated cycles for the same patients,” Human Reproduction, vol. 24, no. 6, pp. 1436–1445, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. V. G. Tusher, R. Tibshirani, and G. Chu, “Significance analysis of microarrays applied to the ionizing radiation response,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 9, pp. 5116–5121, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. C.-C. Chang, Y.-Y. Hsieh, K.-H. Hsu, and C.-S. Lin, “Effects of α and β recombinant FSH (Gonal-F, Puregon) and progesterone upon human endometrial cell proliferation in-vitro: a preliminary study,” Gynecological Endocrinology, vol. 27, no. 2, pp. 110–116, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Haouzi, H. Dechaud, S. Assou, J. De Vos, and S. Hamamah, “Insights into human endometrial receptivity from transcriptomic and proteomic data,” Reproductive BioMedicine Online, vol. 24, no. 1, pp. 23–34, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. J. A. Horcajadas, A. Pellicer, and C. Simón, “Wide genomic analysis of human endometrial receptivity: new times, new opportunities,” Human Reproduction Update, vol. 13, no. 1, pp. 77–86, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Díaz-Gimeno, J. A. Horcajadas, J. A. Martínez-Conejero et al., “A genomic diagnostic tool for human endometrial receptivity based on the transcriptomic signature,” Fertility and Sterility, vol. 95, no. 1, pp. 50–60.e15, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. E. G. Papanikolaou, E. M. Kolibianakis, C. Pozzobon et al., “Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer,” Fertility and Sterility, vol. 91, no. 3, pp. 949–952, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Ochsenkühn, A. Arzberger, V. von Schonfeldt et al., “Subtle progesterone rise on the day of human chorionic gonadotropin administration is associated with lower live birth rates in women undergoing assisted reproductive technology: a retrospective study with 2,555 fresh embryo transfers,” Fertility and Sterility, vol. 98, pp. 347–354, 2012. View at Google Scholar
  37. H. M. Fatemi, K. Doody, G. Griesinger, H. Witjes, and B. Mannaerts, “High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocol,” Human Reproduction, vol. 28, no. 2, pp. 442–452, 2012. View at Google Scholar
  38. R. W. Noyes, A. T. Hertig, and J. Rock, “Dating the endometrial biopsy,” Fertility and Sterility, vol. 1, pp. 3–25, 2012. View at Google Scholar
  39. R. S. Legro, B. A. Ary, R. J. Paulson, F. Z. Stanczyk, and M. V. Sauer, “Premature luteinization as detected by elevated serum progesterone is associated with a higher pregnancy rate in donor oocyte in-vitro fertilization,” Human Reproduction, vol. 8, no. 9, pp. 1506–1511, 1993. View at Google Scholar · View at Scopus
  40. M. A. B. Melo, M. Meseguer, N. Garrido, E. Bosch, A. Pellicer, and J. Remohí, “The significance of premature luteinization in an oocyte-donation programme,” Human Reproduction, vol. 21, no. 6, pp. 1503–1507, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. J. N. Hugues, “Impact of “LH activity” supplementation on serum progesterone levels during controlled ovarian stimulation: a systematic review,” Human Reproduction, vol. 27, no. 1, pp. 232–243, 2012. View at Publisher · View at Google Scholar · View at Scopus